Back to Search
SARAH PALM, MD
MD
Pediatrics Physician
NPI: 1376837377Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
28563(OK)
Research & Publications (20)
Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study.
PMID 19525452·J Nucl Med·2009
3-trial
Panmixia in European eel revisited: no genetic difference between maturing adults from southern and northern Europe.
PMID 19417764·Heredity (Edinb)·2009
4-observational
Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
PMID 18521684·Ann Surg Oncol·2008
4-observational
Differences in radiosensitivity between three HER2 overexpressing cell lines.
PMID 18193218·Eur J Nucl Med Mol Imaging·2008
4-observational
Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice.
PMID 17869670·Int J Radiat Oncol Biol Phys·2007
7-preclinical
Concordance of allozyme and microsatellite differentiation in a marine fish, but evidence of selection at a microsatellite locus.
PMID 17391402·Mol Ecol·2007
4-observational
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2.
PMID 17145538·Int J Radiat Oncol Biol Phys·2006
7-preclinical
Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity.
PMID 17127181·Nucl Med Biol·2006
7-preclinical
Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose.
PMID 16883015·J Nucl Med·2006
7-preclinical
Power for detecting genetic divergence: differences between statistical methods and marker loci.
PMID 16780422·Mol Ecol·2006
7-preclinical
211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
PMID 16330571·J Nucl Med·2005
7-preclinical
Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
PMID 16269606·J Nucl Med·2005
7-preclinical
Spatial genetic structure of northern pike (Esox lucius) in the Baltic Sea.
PMID 15910318·Mol Ecol·2005
4-observational
Genetic population structure of fishes: implications for coastal zone management.
PMID 15865307·Ambio·2005
7-preclinical
Premature ovarian failure associated with a small terminal Xq deletion: narrowing the POF1 region down to Xq27.2/Xq27.3-qter.
PMID 15811012·Clin Genet·2005
5-case
Chronoastrobiology: proposal, nine conferences, heliogeomagnetics, transyears, near-weeks, near-decades, phylogenetic and ontogenetic memories.
PMID 15754855·Biomed Pharmacother·2004
4-observational
Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression.
PMID 15240541·Clin Cancer Res·2004
8-other
Microdosimetry of astatine-211 single-cell irradiation: role of daughter polonium-211 diffusion.
PMID 15000607·Med Phys·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14424 N MAY AVE STE B
OKLAHOMA CITY, OK 73134 - Phone
- (405) 757-7818
Quick Facts
- NPI
- 1376837377
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile